Michael G. Christiansen

Michael G. Christiansen

Auto-generated profile, based on publicly available information

Michael G. Christiansen

Institute for Translational Medicine, ETH Zurich, Zurich, Switzerland

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2022 in Science Robotics
Verified
Journal Article
Closed access
TGT. Gwisai
T. Gwisai
NMN. Mirkhani
N. Mirkhani
MCM. G. Christiansen
M. G. Christiansen
TNT. T. Nguyen
T. T. Nguyen
VLV. Ling
V. Ling
Simone SchuerleSimone Schuerle
Simone Schuerle
Biohybrid bacteria–based microrobots are increasingly recognized as promising externally controllable vehicles for targeted cancer therapy. Magnetic fields in particular have been used as a safe means to transfer energy and direct their motion. Thus far, the magnetic control strategies used in this context rely on poorly scalable magnetic field gradients, require active position feedback, or are ill-suited to diffuse distributions within the body. Here, we present a magnetic torque–driven control scheme for enhanced transport through biological barriers that complements the innate taxis toward tumor cores exhibited by a range of bacteria, shown for Magnetospirillum magneticum as a magnetically responsive model organism. This hybrid control strategy is readily scalable, independent of position feedback, and applicable to bacterial microrobots dispersed by the circulatory system. We observed a fourfold increase in translocation of magnetically responsive bacteria across a model of the vascular endothelium and found that the primary mechanism driving increased transport is torque-driven surface exploration at the cell interface. Using spheroids as a three-dimensional tumor model, fluorescently labeled bacteria colonized their core regions with up to 21-fold higher signal in samples exposed to rotating magnetic fields. In addition to enhanced transport, we demonstrated that our control scheme offers further advantages, including the possibility for closed-loop optimization based on inductive detection, as well as spatially selective actuation to reduce off-target effects. Last, after systemic intravenous injection in mice, we showed significantly increased bacterial tumor accumulation, supporting the feasibility of deploying this control scheme clinically for magnetically responsive biohybrid microrobots.

Verified
Journal Article
Open access
PDF file
MVMatej Vizovisek
Matej Vizovisek
DRDragana Ristanovic
Dragana Ristanovic
SMStefano Menghini
Stefano Menghini
MCMichael G. Christiansen
Michael G. Christiansen
Simone SchuerleSimone Schuerle
Simone Schuerle
In recent decades, dysregulation of proteases and atypical proteolysis have become increasingly recognized as important hallmarks of cancer, driving community-wide efforts to explore the proteolytic landscape of oncologic disease. With more than 100 proteases currently associated with different aspects of cancer development and progression, there is a clear impetus to harness their potential in the context of oncology. Advances in the protease field have yielded technologies enabling sensitive protease detection in various settings, paving the way towards diagnostic profiling of disease-related protease activity patterns. Methods including activity-based probes and substrates, antibodies, and various nanosystems that generate reporter signals, i.e., for PET or MRI, after interaction with the target protease have shown potential for clinical translation. Nevertheless, these technologies are costly, not easily multiplexed, and require advanced imaging technologies. While the current clinical applications of protease-responsive technologies in oncologic settings are still limited, emerging technologies and protease sensors are poised to enable comprehensive exploration of the tumor proteolytic landscape as a diagnostic and therapeutic frontier. This review aims to give an overview of the most relevant classes of proteases as indicators for tumor diagnosis, current approaches to detect and monitor their activity in vivo, and associated therapeutic applications.

9 March 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
NMNima Mirkhani
Nima Mirkhani
MCMichael G. Christiansen
Michael G. Christiansen
TGTinotenda Gwisai
Tinotenda Gwisai
SMStefano Menghini
Stefano Menghini
Simone SchuerleSimone Schuerle
Simone Schuerle
Rotating magnetic fields enable biomedical microrobots to overcome physiological barriers and promote extravasation and accumulation in tumors. Nevertheless, targeting deeply situated tumors requires suppression of off-target actuation in healthy tissue. Here, we investigate a control strategy for applying spatially selective torque density to microrobots by combining rotating fields with magnetostatic selection fields. Taking magnetotactic bacteria as diffuse torque-based actuators, we numerically model off-target torque suppression, indicating the feasibility of centimeter to millimeter resolution for human applications. We study focal torque application in vitro, observing off-target suppression of actuation-dependent effects such as colonization of bacteria in tumor spheroids. We then design and construct a mouse-scale torque-focusing apparatus capable of maneuvering the focal point. Applying this system to a mouse tumor model increased accumulation of intravenously injected bacteria within tumors receiving focused actuation compared to non-actuated or globally actuated groups. This control scheme combines the advantages of torque-based actuation with spatial targeting.

8 October 2022 in Trends in Biotechnology
Verified
Journal Article
Closed access
PCParth Chansoria
Parth Chansoria
HLHao Liu
Hao Liu
MCMichael G. Christiansen
Michael G. Christiansen
Simone SchuerleSimone Schuerle
Simone Schuerle
MZMarcy Zenobi-Wong
Marcy Zenobi-Wong

5 January 2024 in Communications Engineering
Verified
Journal Article
Open access
PDF file
YYYimo Yan
Yimo Yan
CSChao Song
Chao Song
ZSZaiyi Shen
Zaiyi Shen
YZYuechen Zhu
Yuechen Zhu
XNXingyu Ni
Xingyu Ni
Simone SchuerleSimone Schuerle
Simone Schuerle
Swarms of soft microrobots controlled by minimally invasive magnetic fields show promise as biomedical agents. The collective behaviour of such swarms, governed by magnetic and hydrodynamic interactions, emerges from the properties of their individual constituents. The introduction of both magnetic and structural anisotropy into microrobots expands the possibilities for tailoring and predetermining interactions and collective behaviours that result. Unfortunately, current methods for large-scale production of soft microrobots, typically result in isotropic properties. Herein, by combining simulation-guided design and droplet-based microfluidics, we present a versatile, high-throughput technique for fabricating soft microrobots with programmable structural and magnetic anisotropy. Such microrobots consist of iron oxide nanoparticles organized into supra-domain structures and entrapped in a hydrogel matrix that can be elongated independently of its magnetic properties. By applying rotating magnetic fields to resulting swarms, distinct collective behaviours are produced, including gas-like formations, variable crystals, and heterogeneous motions.

3 September 2021 in Lab on a Chip
Verified
Journal Article
Open access
PDF file
DADaphne O. Asgeirsson
Daphne O. Asgeirsson
MCMichael G. Christiansen
Michael G. Christiansen
TVThomas Valentin
Thomas Valentin
LSLuca Somm
Luca Somm
NMNima Mirkhani
Nima Mirkhani
Simone SchuerleSimone Schuerle
Simone Schuerle
Rod-shaped magnetic microprobes are employed to assess and actuate extracellular matrix models in 3D from the perspective of single cells. To achieve this, our method combines magnetic field control, physical modeling, and image analysis.